Thrombocytopenia Clinical Trials in Wuhan, Hubei
6 recruitingWuhan, Hubei, China
Showing 1–6 of 6 trials
Recruiting
Early Phase 1
Safety and Efficacy of PRG-1801 in Recurrent/Refractory Primary Immune Thrombocytopenia (ITP)
Immune Thrombocytopenia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology6 enrolled2 locationsNCT06519565
Recruiting
Phase 1
Phase I Study of SHR-2173 Injection in Patients With Primary Immune Thrombocytopenia
Immune Thrombocytopenia
Guangdong Hengrui Pharmaceutical Co., Ltd10 enrolled1 locationNCT07206758
Recruiting
Phase 2
Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia
ThrombocytopeniaConnective Tissue Diseases
Beijing Hospital296 enrolled23 locationsNCT05998759
Recruiting
Phase 1
UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia
Acute Myeloid LeukemiaThrombocytopeniaNeutropenia+3 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology9 enrolled1 locationNCT06245746
Recruiting
Phase 2Phase 3
Efficacy and Safety of Avatrombopag in the Treatment of Thrombocytopenia After Haplo-HSCT
ThrombocytopeniaStem Cell Transplant Complications
Peking University People's Hospital142 enrolled14 locationsNCT06202625
Recruiting
Phase 3
Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia
Chronic Primary Immune Thrombocytopenia (ITP)
Beijing InnoCare Pharma Tech Co., Ltd.195 enrolled45 locationsNCT06004856